UNLIMITED TURBO SHORT - MERCK & CO. | Real-time Euronext Paris 14:23:40 14/05/2024 BST | ||
| 2.783 EUR | -2.01% |
|
| Current month | +6.73% | ||
| 1 month | -8.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/05/24 | 2.783 | -2.01% |
| 13/05/24 | 2.84 | +7.70% |
| 10/05/24 | 2.637 | -1.93% |
| 09/05/24 | 2.689 | -1.03% |
| 08/05/24 | 2.717 | -2.76% |
Real-time Euronext Paris
Last update May 14, 2024 at 02:23 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| HR7MB | |
| ISIN | NLBNPNL2N6M4 |
| Date issued | 05/02/2024 |
| Strike | 157.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.9 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.615 € |
|---|---|
| Lowest since issue | 2.34 € |
| Spread | 0.102 € |
| Spread % | 3.58% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.3
USD
Average target price
141.6
USD
Spread / Average Target
+9.55%
- Stock Market
- Certificates
- HR7MB Certificat
